Trial Site Detail

 

Drug:
PLX3397 (PLX108-01)
Trial:
Safety Study of PLX108-01 in Patients With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Vanderbilt-Ingram Cancer Center

2220 Pierce Ave.     691 Preston Building
Nashville , TN 37232
USA

 

Principal Investigator:
Igor Puzanov, MD
Contact:
Wendy VerMeulen, RN 800-811-8480 wendy.vermeulen@vanderbilt.edu
Activation Status of this Site:
Closed
Notes about this Site:
Vanderbilt-Ingram Cancer Center Website:
http://www.vicc.org/ct/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.